David Miles Meredith, M.D.,Ph.D.
This page shows the publications David Meredith has written about Genetic Vectors.
Functional expression of thymidine kinase in human leukaemic and colorectal cells, delivered as EGFP fusion protein by herpesvirus saimiri-based vector. Cancer Gene Ther. 2004 Sep; 11(9):613-24.
Stable marker gene transfer into human bone marrow stromal cells and their progenitors using novel herpesvirus saimiri-based vectors. J Hematother Stem Cell Res. 2000 Aug; 9(4):573-81.
A herpesvirus saimiri-based gene therapy vector with potential for use in cancer immunotherapy. Cancer Gene Ther. 2000 Jul; 7(7):1077-85.
Assessment of Herpesvirus saimiri as a potential human gene therapy vector. J Med Virol. 1999 Mar; 57(3):269-77.
Herpesvirus saimiri-based gene delivery vectors maintain heterologous expression throughout mouse embryonic stem cell differentiation in vitro. Gene Ther. 2000 Mar; 7(6):464-71.
The herpes simplex virus type 1 tegument protein VP22 is encoded by gene UL49. J Gen Virol. 1992 Mar; 73 ( Pt 3):723-6.
Truncated adenomatous polyposis coli (APC) tumour suppressor protein can undergo tyrosine phosphorylation. Eur J Cancer. 2000 Mar; 36(4):525-32.
Location of open reading frames coding for equine herpesvirus type-1 glycoproteins with homology to gE and gI of herpes simplex virus. Am J Vet Res. 1991 Aug; 52(8):1252-7.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.